Rheumatoid arthritis - A new questionnaire for detecting central pain sensitisation in people
Learn more about a new questionnaire for detecting central pain sensitisation in people with rheumatoid arthritis.
Learn more about a new questionnaire for detecting central pain sensitisation in people with rheumatoid arthritis.
Learn about our research into how gut bacteria leads to the development of rheumatoid arthritis in people who are at risk of developing the condition.
Read more about our research into neutrophils (a type of white blood cell) and a new way of switching off unwanted inflammation in rheumatoid arthritis.
Learn about our research into testing the theory that RA is sustained and perpetuated by diseased stem cells in the joint that give rise to abnormal tissue.
Learn about our research into a new app which aims to explore mental and physical health support - providing personalised treatment for people with arthritis.
Learn more about if the differences in the microbiome be used to understand the effectiveness of drugs in rheumatoid arthritis.
Learn more can we personalise treatment for rheumatoid arthritis by looking at a patient’s immune cells in the blood?
Learn about our research into how IRF5, a molecule that causes inflammation in rheumatoid arthritis, is controlled and identifying how it might be blocked.
Learn about our research into a computer model to predict which molecules activate the neutrophils (white blood cells), to prevent their damaging effects.
Read more about defining the role of cell migration in the initiation and regulation of pathogenesis in inflammatory arthritis.
Learn more about our research into investigating a new method of drug delivery to observe its long term effects on the symptoms of rheumatoid arthritis.
Read about our research on developing a device to monitor arthritis flare ups at home.
Learn more about our research into comparing ultrasound to a new, quicker imaging technique for assessing inflammation and predicting future joint damage.
Learn about our research project to produce a new, well designed wrist support for patients with wrist problems and to better inform health care professionals.
Learn about our research into a new rheumatoid arthritis treatment based on antibodies that block the pro-inflammatory activity of a protein called tenascin-C.
Read about our research on developing new treatments to target FGF in people with rheumatoid arthritis who do not respond to other treatments
Learn about our research into predicting and preventing rheumatoid arthritis - from the views of patients, relatives, carers, and healthcare professionals.
Learn about our research into gut bacteria - its influence on developing RA and how differences can be correlated with features of the patients' immune cells.
Learn more about does steroid production in patients with rheumatoid arthritis cause joint destruction, muscle wasting and bone loss?
Learn about our research into creating and evaluating computer design software to enable virtual splint design in preparation for 3D printing, for OA and RA.
Learn about our research into how platelet molecules (fragments of cells that help blood to clot) regulate other molecules in the joint in rheumatoid arthritis.
Learn about our research into the genes controlled by the three RA associated regions, the mechanism to control them and where the changes are important.
Read more about how anti-TNF therapy makes T-cells switch roles, from causing inflammation to reducing inflammation.
Read about our research, which aims to look at if rheumatoid arthritis symptoms and inflammation are linked to the body clock and how gut bacteria plays a role.
Read about our research on how can digital support platforms assist people with rheumatoid arthritis increase physical activity levels.
Learn about our research into some important questions highlighted in clinical trials on the use of the dendritic cells (immune cells) as an immunotherapy.
Learn about our research into how a group of ‘protective’ macrophages may help to prevent inflammation and maintain joint re-mission in rheumatoid arthritis.
Learn about our research into how a lack of omega 3 can lead to the inability to switch off inflammation and if changing diet can stop persistent inflammation.
Learn about our research into why the binding of an antibody to the macrophage cell changes the way it generates energy, producing toxins/inflammatory signals.
Learn about our research into how the communication between fibroblasts (cells in connective tissue) and macrophages (white blood cells) causes inflammation.
Learn about our research into whether inflammatory cells in periodontitis leads to disruption of the immune system - contributing to arthritis symptoms.
Learn about our research which aims to identify how genetic changes might increase the risk of developing rheumatoid arthritis - leading to better treatments.
Learn about our research in cutting-edge technologies to study the way the stem cells maintain normal joint tissues or become abnormal in joint diseases.
Learn about our research into how microvesicles provide protection to cartilage and if they can be loaded with drugs to directly target damaged cartilage.
Learn about our project for creating a network of rheumatology internships for health-care professionals in universities with outstanding clinical researchers.
Learn about our research which aims to understand why there is a variation in care quality and treatment success between different rheumatology departments.
Read more about stopping the development of harmful T-cells - a new approach to treating rheumatoid arthritis.
Read about our research on studying immune cells to predict the onset and progression of rheumatoid arthritis, and predict response to JAK inhibitor medication.
Read about the interactions between different cells that can cause joint inflammation in rheumatoid arthritis.
Learn more about support for the Norfolk Arthritis Register (NOAR) as part of the Arthritis Research UK Centre for Epidemiology.
Learn about our research investigating the additional conditions people with musculoskeletal conditions have and how they affect their quality of life.
Learn about our research aiming to test whether mediators (proteins), along with drugs that increase their levels, can promote healing in inflammatory cells.
Learn about our research project aiming to create a network between UK and Japanese neuroscientists and understand the relationship between movement and pain.
Learn about our Special Strategic Award at the University of Manchester for UK Research in Musculoskeletal Epidemiology (RIME) and rheumatoid arthritis.
Learn about our research into correcting the damaging effect that enzymes have on joint tissue in many forms of arthritis, using recently discovered proteins.
Learn about our research into the structure of the DNA of a dyeing cell, which causes inflammation, and how this information can be used to stop inflammation.
Learn about our research into understanding how NaVs (proteins) interact to create electrical signals in nerves, which result in pain in those with arthritis.
Learn about our research into determining the role of dendritic integrins (which control/coordinate the immune system) in the development of arthritic disease.
Read about understanding the role of gut bacteria and regulatory B cells in controlling rheumatoid arthritis and lupus.
Learn about our research which aims to further understand the role that a type of white blood cell, called neutrophils, play in joint damage and inflammation.
Learn about our research into why fibroblasts change their normal peaceful behaviour into an aggressive behaviour in patients with rheumatoid arthritis.
Learn about our research which aims to understand how inflammation can lead to chronic pain that can persist long after the inflammation has resolved.
Learn about our research which aims to understand how DNA changes affect genes and cause rheumatoid arthritis, using new methods where previous studies failed.
Learn more about using magnetic stimulation to understand how specific areas of the brain contribute to pain experienced in rheumatoid arthritis.
Read more about what information, skills and support do patients need to become 'activated' in their healthcare.
Read more about what is the best route for injecting tolerogenic dendritic cells into people with rheumatoid arthritis?
Learn about our research into how the diversity and severity of joint inflammation in different patients is controlled, which could lead to improving treatment.
Learn about our research into whether a work rehabilitation programme (WORKWELL) will improve the working lives of people with inflammatory arthritis.